Citigroup’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.8K Sell
14,622
-10,420
-42% -$21.2K ﹤0.01% 4246
2025
Q1
$40.8K Buy
25,042
+5,025
+25% +$8.19K ﹤0.01% 4165
2024
Q4
$36.6K Buy
20,017
+1,091
+6% +$2K ﹤0.01% 4313
2024
Q3
$109K Buy
18,926
+13,218
+232% +$76.4K ﹤0.01% 3956
2024
Q2
$46.1K Sell
5,708
-29,472
-84% -$238K ﹤0.01% 3895
2024
Q1
$488K Buy
35,180
+35,171
+390,789% +$488K ﹤0.01% 2873
2023
Q4
$57 Sell
9
-278
-97% -$1.76K ﹤0.01% 4763
2023
Q3
$1.34K Sell
287
-118
-29% -$550 ﹤0.01% 4288
2023
Q2
$2.17K Sell
405
-154,594
-100% -$829K ﹤0.01% 4539
2023
Q1
$1.53M Buy
154,999
+56,663
+58% +$558K ﹤0.01% 1701
2022
Q4
$1.84M Sell
98,336
-69,522
-41% -$1.3M ﹤0.01% 1577
2022
Q3
$3.48M Buy
167,858
+39,538
+31% +$819K ﹤0.01% 1284
2022
Q2
$2.66M Buy
128,320
+101,946
+387% +$2.12M ﹤0.01% 1413
2022
Q1
$1.14M Sell
26,374
-37,520
-59% -$1.62M ﹤0.01% 2231
2021
Q4
$3.83M Buy
63,894
+32,867
+106% +$1.97M ﹤0.01% 1470
2021
Q3
$2.67M Sell
31,027
-20,627
-40% -$1.77M ﹤0.01% 1707
2021
Q2
$5.75M Buy
51,654
+9,833
+24% +$1.09M ﹤0.01% 1331
2021
Q1
$4.66M Buy
41,821
+31,773
+316% +$3.54M ﹤0.01% 1371
2020
Q4
$1.07M Buy
10,048
+3,172
+46% +$337K ﹤0.01% 2127
2020
Q3
$957K Sell
6,876
-15,967
-70% -$2.22M ﹤0.01% 1894
2020
Q2
$7.39M Buy
22,843
+14,322
+168% +$4.63M 0.01% 921
2020
Q1
$761K Buy
8,521
+1,559
+22% +$139K ﹤0.01% 1994
2019
Q4
$276K Buy
6,962
+1,807
+35% +$71.6K ﹤0.01% 2972
2019
Q3
$127K Sell
5,155
-2,150
-29% -$53K ﹤0.01% 3322
2019
Q2
$257K Buy
7,305
+1,216
+20% +$42.8K ﹤0.01% 3068
2019
Q1
$273K Sell
6,089
-15,252
-71% -$684K ﹤0.01% 2920
2018
Q4
$1.02M Buy
21,341
+4,923
+30% +$236K ﹤0.01% 1999
2018
Q3
$1.1M Buy
16,418
+3,462
+27% +$231K ﹤0.01% 1932
2018
Q2
$609K Sell
12,956
-3,187
-20% -$150K ﹤0.01% 2206
2018
Q1
$912K Sell
16,143
-1,812
-10% -$102K ﹤0.01% 1873
2017
Q4
$890K Buy
17,955
+4,895
+37% +$243K ﹤0.01% 1949
2017
Q3
$994K Buy
13,060
+8,662
+197% +$659K ﹤0.01% 1944
2017
Q2
$414K Buy
4,398
+683
+18% +$64.3K ﹤0.01% 2528
2017
Q1
$295K Sell
3,715
-10,975
-75% -$872K ﹤0.01% 2731
2016
Q4
$1.22M Buy
14,690
+8,279
+129% +$689K ﹤0.01% 2226
2016
Q3
$717K Buy
6,411
+1,520
+31% +$170K ﹤0.01% 2189
2016
Q2
$542K Sell
4,891
-4,468
-48% -$495K ﹤0.01% 2152
2016
Q1
$978K Buy
9,359
+4,345
+87% +$454K ﹤0.01% 2093
2015
Q4
$405K Sell
5,014
-5,653
-53% -$457K ﹤0.01% 2514
2015
Q3
$740K Buy
10,667
+5,454
+105% +$378K ﹤0.01% 1928
2015
Q2
$510K Sell
5,213
-266
-5% -$26K ﹤0.01% 2134
2015
Q1
$536K Sell
5,479
-801
-13% -$78.4K ﹤0.01% 2236
2014
Q4
$691K Buy
6,280
+930
+17% +$102K ﹤0.01% 2151
2014
Q3
$632K Buy
5,350
+973
+22% +$115K ﹤0.01% 1872
2014
Q2
$568K Sell
4,377
-2,239
-34% -$291K ﹤0.01% 1926
2014
Q1
$1.06M Sell
6,616
-664
-9% -$106K ﹤0.01% 1551
2013
Q4
$1.01M Buy
7,280
+416
+6% +$57.9K ﹤0.01% 1834
2013
Q3
$682K Buy
6,864
+907
+15% +$90.1K ﹤0.01% 1782
2013
Q2
$228K Buy
+5,957
New +$228K ﹤0.01% 2633